Trial Scorecards

Trial Scorecards

Issue: August 2018
August 09, 2018
1 min read
Save

Trial Scorecard: MERCURY PE

Issue: August 2018
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Comparison of early discharge on rivaroxaban (Xarelto, Janssen) vs. standard of care in patients with low-risk pulmonary embolism.

Trial Scorecard: MERCURY PE